Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;24(7):876-877.
doi: 10.1111/codi.16111. Epub 2022 Mar 24.

Expanding the utility of the watch-and-wait approach to stage IV patients: Results from the Dutch consortium

Mufaddal Kazi  1 , Avanish Saklani  1
Affiliations
Comment

Expanding the utility of the watch-and-wait approach to stage IV patients: Results from the Dutch consortium

Mufaddal Kazi et al. Colorectal Dis. 2022 Jul.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Custers PA, Hupkens BJP, Grotenhuis BA, Kuhlmann KFD, Breukink SO, Beets GL, et al. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery? Colorectal Dis. 2022. https://doi.org/10.1111/codi.16034
    1. van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;23(391):2537-45.
    1. Engineer R, Saklani A, D'souza A, Arya S, Kumar S, Ostwal V, et al. Watch and wait approach after neoadjuvant chemoradiotherapy in rectal cancer: initial experience in the Indian subcontinent. Indian J Surg Oncol. 2021;1(12):664-70.
    1. Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG 0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789-99.

LinkOut - more resources